IP Library › Granted Patent US 8,501,174
Granted Patent B2
US 8,501,174 · App. 12/825,116 · Granted Aug 6, 2013

Prevention and treatment of ocular side effects with a cyclosporin

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,501,174
App. No.
12/825,116
Granted
Aug 6, 2013
Kind
B2
Abstract

Therapeutic methods are disclosed herein.

Claims (4)

1. A method comprising administering cyclosporin A to an eye of a mammal in combination with administration of rituximab, wherein said method is effective in treating abnormal lacrimation, keratitis, or conjunctivitis.

2. The method of claim 1 wherein said method is effective in treating abnormal lacrimation.

3. The method of claim 1 wherein said method is effective in treating keratitis.

4. The method of claim 1 wherein said method is effective in treating conjunctivitis.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 12, 2017
From: ALLERGAN, INC.
To: SAINT REGIS MOHAWK TRIBE
Reel/Frame 043830/0446 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 10, 2013
From: FEINERMAN, GREGG; BARTH, NEIL; SCHIFFMAN, RHETT M.; BARNETT, PAMELA S.
To: ALLERGAN, INC.
Reel/Frame 030190/0353 →